Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Regulus Therapeutics revenue
Regulus Therapeutics's revenue is $10.0 million.
What is Regulus Therapeutics's revenue?
- Regulus Therapeutics's revenue growth from 2011 to 2020 is -27.43%.
- Regulus Therapeutics has 25 employees, and the revenue per employee ratio is $400,240.
- Regulus Therapeutics's peak quarterly revenue was $10.9M in 2015(4).
- Regulus Therapeutics peak revenue was $20.8M in 2015.
- Regulus Therapeutics annual revenue for 2019 was 6.8M, 9,388.89% growth from 2018.
- Regulus Therapeutics annual revenue for 2020 was 10.0M, 46.46% growth from 2019.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Regulus Therapeutics historical revenue
Regulus Therapeutics's peak revenue was $20.8M in 2015. The peak quarterly revenue was $10.9M in 2015(4).
Regulus Therapeutics's revenue increased from $13.8m in 2011 to $10.0M currently. That's a -27.43% change in annual revenue.
Regulus Therapeutics annual revenue
Regulus Therapeutics annual revenue over time
| Fiscal year / year | Regulus Therapeutics revenue |
|---|---|
| 2011 | $13.8M |
| 2012 | $12.7M |
| 2013 | $19.6M |
| 2014 | $7.7M |
| 2015 | $20.8M |
| 2016 | $1.2M |
| 2017 | $72,000 |
| 2018 | $72,000 |
| 2019 | $6.8M |
| 2020 | $10.0M |
Rate Regulus Therapeutics' financial transparency
Regulus Therapeutics annual growth
Regulus Therapeutics saw the greatest revenue growth in 2019, when revenue increased by 9,388.89%.
Regulus Therapeutics had the lowest revenue growth in 2016, when revenue changed by -94.25%.
Regulus Therapeutics annual growth rate over time
| Year | Regulus Therapeutics growth |
|---|---|
| 2012 | -8%↓ |
| 2013 | 54%↑ |
| 2014 | -61%↓ |
| 2015 | 171%↑ |
| 2016 | -94%↓ |
| 2017 | -94%↓ |
| 2018 | 0%↓ |
| 2019 | 9389%↑ |
| 2020 | 46%↑ |
Regulus Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Regulus Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2012 | - | - | - | - |
| 2013 | - | - | - | - |
| 2014 | - | - | - | - |
| 2015 | - | - | - | - |
| 2016 | - | - | - | - |
| 2017 | - | - | - | - |
| 2018 | - | - | - | - |
| 2019 | - | - | - | - |
| 2020 | - | - | - | - |
Regulus Therapeutics jobs nearby
Do you work at Regulus Therapeutics?
Is Regulus Therapeutics transparent about its revenue structure?
Regulus Therapeutics financial information
| CEO | Joseph P. Hagan |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 25 |
| Date Founded | 2007 |
| Headquarters | San Diego, California |
| Number of Locations | 1 |
| Revenue | $10.0M |
| Net Income | -$28,321,000 |
| PE Ratio | -2.71 |
| Tax Rate | 0.0% |
| Market Capitalization | $125.6M |
| Total Assets | $46,716,000 |
| Ticker | RGLS |
Regulus Therapeutics jobs you might like
Regulus Therapeutics financing
Regulus Therapeutics received early financing of $20.0M on 2009-03-04.
| Series | Round size | Date |
|---|---|---|
| Series A | $20M | 03/2009 |
| Undisclosed | $10M | 10/2010 |
| Post Ipo Debt | $25M | 10/2012 |
| Post Ipo Equity | $49.2M | 07/2013 |
| Post Ipo Equity | $10.0M | 02/2014 |
| Post Ipo Equity | $103.5M | 10/2014 |
| Post Ipo Debt | $30M | 06/2016 |
| Post Ipo Equity | $43M | 07/2017 |
| Post Ipo Equity | $16.7M | 05/2019 |
| Post Ipo Equity | $19.4M | 12/2020 |
| Post Ipo Equity | $34.6M | 11/2021 |
Regulus Therapeutics investors
| Investors | Security type |
|---|---|
| SANOFI | Undisclosed |
| Oxford Finance LLC | Post Ipo Debt |
| New Enterprise Associates (NEA) | Post Ipo Equity |
| Federated Kaufmann Fund | Post Ipo Equity |
Regulus Therapeutics competitors
Regulus Therapeutics's top competitor, Merck, earned an annual revenue of $64.2B.
Regulus Therapeutics's smallest competitor is Arena Pharmaceuticals with revenue of $54.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 785 |
| Human Genome Sciences | $70,157 | $131.0M | 1,000 | - |
| Merck | $90,328 | $64.2B | 74,000 | 1,486 |
| Alnylam Pharmaceuticals | $81,014 | $2.2B | 1,323 | 1 |
| Trevena | $64,889 | $3.8M | 25 | - |
| Cubist Pharmaceuticals | $91,725 | $926.4M | 873 | - |
| Quidel | $71,489 | $1.7B | 1,500 | - |
| Intellia Therapeutics | $79,975 | $57.9M | 211 | 17 |
| Genocea | $53,221 | - | 59 | - |
| Ligand Pharmaceuticals | $82,001 | $241.5M | 116 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Regulus Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Regulus Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Regulus Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Regulus Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Regulus Therapeutics. The data presented on this page does not represent the view of Regulus Therapeutics and its employees or that of Zippia.
Regulus Therapeutics may also be known as or be related to Regulus Therapeutics, Regulus Therapeutics Inc, Regulus Therapeutics Inc. and Regulus Therapeutics, Inc.